BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 73 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q3 2023. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $343,717 | -37.7% | 119,762 | +9.6% | 0.01% | -33.3% |
| Q2 2023 | $551,930 | +1246.2% | 109,293 | +632.0% | 0.01% | +1100.0% |
| Q1 2022 | $41,000 | -48.8% | 14,931 | 0.0% | 0.00% | -50.0% |
| Q4 2021 | $80,000 | -36.5% | 14,931 | 0.0% | 0.00% | -33.3% |
| Q3 2021 | $126,000 | -51.4% | 14,931 | -29.8% | 0.00% | -62.5% |
| Q2 2021 | $259,000 | -45.1% | 21,284 | +9.4% | 0.01% | -55.6% |
| Q1 2021 | $472,000 | -59.9% | 19,449 | -47.1% | 0.02% | -59.1% |
| Q4 2020 | $1,178,000 | -9.1% | 36,761 | -14.3% | 0.04% | -43.6% |
| Q3 2020 | $1,296,000 | +39.5% | 42,874 | +94.6% | 0.08% | +21.9% |
| Q2 2020 | $929,000 | – | 22,028 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 3,449,845 | $104,289,000 | 4.42% |
| Boxer Capital, LLC | 2,014,858 | $60,909,000 | 2.10% |
| RA Capital Management | 2,589,904 | $78,293,000 | 1.43% |
| Artal Group S.A. | 1,521,517 | $45,995,000 | 1.12% |
| Ikarian Capital, LLC | 358,941 | $10,851,000 | 0.78% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 802,511 | $24,260,000 | 0.59% |
| Bellevue Group AG | 1,403,000 | $42,413,000 | 0.59% |
| Logos Global Management LP | 123,465 | $3,732,000 | 0.48% |
| Casdin Capital, LLC | 289,395 | $8,748,000 | 0.39% |
| HighVista Strategies LLC | 16,391 | $496,000 | 0.36% |